# Situation: A 45-year-old man is on day 5 after a living-donor kidney transplant. He takes tacrolimus at 8:00 AM and 8:00 PM, mycophenolate, and prednisone. He has an indwelling urinary catheter, and his urine output over the past day was 150–200 mL/h. A tacrolimus trough level is ordered. When should the blood be drawn?

> source: MyMerci (mymerci.kr)  
> url: https://mymerci.kr/pages/nclex_q.php?qn_id=629828  
> language: ko  
> subject: Nursing Practice III — Care of Clients with Problems in Surgery, Oxygenation, Fluid and Electrolytes, Infectious, Inflammatory and Immunologic Response, Cellular Aberrations

## 문제

Situation: A 45-year-old man is on day 5 after a living-donor kidney transplant. He takes tacrolimus at 8:00 AM and 8:00 PM, mycophenolate, and prednisone. He has an indwelling urinary catheter, and his urine output over the past day was 150–200 mL/h.

A tacrolimus trough level is ordered. When should the blood be drawn?

## 보기

1. Two hours after the 8:00 AM dose
2. Just before the 8:00 AM dose **✔ 정답**
3. At noon, midway between the doses
4. At bedtime, after the 8:00 PM dose

**정답: 2**

## 해설

A trough level measures the lowest drug concentration, which occurs just before the next dose. The morning dose is held until the sample is drawn and then given on time. Levels drawn at other times cannot be compared with the trough target range.

## 심화 해설

A trough level is defined as the lowest serum drug concentration during a dosing interval, and it is measured immediately before the next scheduled dose is due. For a patient taking tacrolimus at 8:00 AM and 8:00 PM, the blood sample must be drawn just before the 8:00 AM dose, with the morning dose held until the sample is collected. This timing ensures the result reflects the true nadir concentration and can be compared against the established trough target range.

Therapeutic drug monitoring (TDM) for tacrolimus relies on consistent sampling relative to dosing because tacrolimus has a narrow therapeutic index. A level drawn two hours after the dose captures the absorption or distribution phase, not the trough. A midday sample falls between peak and trough and cannot be interpreted using trough reference values. A bedtime sample after the evening dose is also inappropriate because it does not represent the pre-dose nadir for the morning interval.

The clinical consequence of incorrect sampling timing is significant. If a blood sample is drawn too early after a dose, the measured concentration is falsely elevated. This can lead a clinician to reduce the tacrolimus dose unnecessarily, placing the transplant recipient at risk of acute rejection. Conversely, a sample drawn late—after a missed or delayed dose—may be falsely low and prompt an unsafe dose increase, increasing the risk of nephrotoxicity, neurotoxicity, and other adverse effects.

The morning dose is held until the trough sample is drawn, and then the dose is given on time to maintain the regular 12-hour schedule. This practice prevents the morning dose from contaminating the trough measurement while preserving the patient’s dosing rhythm. In the inpatient setting, coordination between nursing staff and the phlebotomy team is essential so the draw occurs before the 8:00 AM administration.

The importance of sampling timing is not unique to tacrolimus. The same principle applies to other drugs monitored by trough levels, including cyclosporine, vancomycin, and voriconazole. Key point! A case report on voriconazole TDM demonstrated that misinterpretation of a drug concentration occurred because the sample was not collected at the correct time relative to dosing [1]. The clinical pharmacist identified that the timing error—not true drug accumulation—explained the unexpectedly high result. This reinforces that the value of any drug level depends entirely on when the sample was drawn relative to the last dose.

For this patient on day 5 after living-donor kidney transplant, the high urine output of 150–200 mL/h indicates good early graft function, but tacrolimus dosing still requires careful TDM to balance immunosuppression against toxicity. Watch out! Drawing the level at noon or after the evening dose produces a value that cannot be matched to the trough target range, and any dose adjustment based on such a value would be clinically unsafe.

| Sampling time | Type of level | Interpretation for tacrolimus |
| --- | --- | --- |
| Just before 8:00 AM dose | Trough | Correct; reflects lowest concentration and is comparable to target range |
| Two hours after 8:00 AM dose | Absorption/distribution phase | Falsely elevated; not a trough |
| Noon (midway between doses) | Random level | Cannot be interpreted using trough reference values |
| After 8:00 PM dose | Post-dose level | Not the pre-dose nadir for the next interval |

In nursing practice, the correct sequence is to verify the order for a trough level, ensure the next dose has not yet been given, draw the blood sample, document the exact collection time, and then administer the scheduled dose. Documenting the precise time of both the last dose and the blood draw is essential for accurate interpretation by the clinical pharmacist or provider. A trough level without a documented dosing time has limited clinical utility because the interval between dose and sample determines whether the result is valid [1].References (research sources)

- [1]Voriconazole pseudotoxicity: a case report highlighting the importance of sampling timing in TDM interpretation by clinical pharmacists.Case reportDeng XM, Xu Y, Xie ZQ, Xu JJ, Mao KL, Sun HY. (2026) · DOI: 10.3389/fmed.2026.1878131

## 임상 시나리오

Tacrolimus Trough TimingDraw just before the next scheduled dose
For a patient taking tacrolimus at 8:00 AM and 8:00 PM, the trough sample should be drawn just before the 8:00 AM dose. The morning dose is held until after the sample is collected, then given on time.

A trough level measures the lowest drug concentration during the dosing interval. Only a pre-dose sample can be compared against the established trough target range for tacrolimus.

CautionDrawing too early after a dose yields a falsely elevated level, risking unnecessary dose reduction and acute rejection. Drawing late after a missed dose yields a falsely low level, risking unsafe dose increase and nephrotoxicity or neurotoxicity.

## 핵심 개념

- **Trough level** — The lowest serum drug concentration during a dosing interval, measured immediately before the next scheduled dose.
- **Therapeutic drug monitoring** — Measurement of drug levels to maintain a narrow therapeutic range, especially for drugs like tacrolimus with high interpatient variability.
- **Tacrolimus** — A calcineurin inhibitor immunosuppressant used to prevent organ rejection, requiring TDM due to its narrow therapeutic index.
- **Narrow therapeutic index** — A small margin between effective and toxic drug concentrations, making precise dosing and monitoring critical.
- **Nadir** — The lowest point of drug concentration in the blood, occurring just before the next dose is administered.

## 같은 주제 문제

- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629716)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629717)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629718)
- [Situation: A 29-year-old woman has a pre-employment medical examination at a private manuf…](https://mymerci.kr/pages/nclex_q.php?qn_id=629719)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629720)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629721)
- [Situation: A 34-year-old man was diagnosed with human immunodeficiency virus (HIV) infecti…](https://mymerci.kr/pages/nclex_q.php?qn_id=629722)
- [Situation: A 41-year-old man is admitted to the medical ward with weakness that began in b…](https://mymerci.kr/pages/nclex_q.php?qn_id=629723)

---

More free questions: [기출문제](https://mymerci.kr/)

_학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._